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http://dx.doi.org/10.1016/j.stemcr.2016.06.007SUMMARYGonadotropin-releasing hormone (GnRH) neurons regulate human puberty and reproduction. Modeling their development and func-
tion in vitro would be of interest for both basic research and clinical translation. Here, we report a three-step protocol to differentiate
human pluripotent stem cells (hPSCs) into GnRH-secreting neurons. Firstly, hPSCs were differentiated to FOXG1, EMX2, and PAX6
expressing anterior neural progenitor cells (NPCs) by dual SMAD inhibition. Secondly, NPCs were treated for 10 days with FGF8, which
is a key ligand implicated in GnRH neuron ontogeny, and finally, the cells were matured with Notch inhibitor to bipolar TUJ1-positive
neurons that robustly expressedGNRH1 and secretedGnRHdecapeptide into the culturemedium. The protocol was reproducible both in
human embryonic stem cells and induced pluripotent stem cells, and thus provides a translational tool for investigating themechanisms
of human puberty and its disorders.INTRODUCTION
The onset of puberty is regulated by a small population of
hypothalamic gonadotropin-releasing hormone (GnRH)
neurons, which secreteGnRHdecapeptide to the hypophy-
seal portal system. Unlike other neuroendocrine cell types
that reside in the hypothalamus, GnRH neurons are born
outside the CNS in the frontonasal area. The olfactory pit,
which is formed by the olfactory placodes (OP) and sur-
roundingmesenchyme, provides a niche for GnRH neuron
specification. Prenatally, GnRH neurons migrate from the
frontonasal mesenchyme along with olfactory axons to
the forebrain and into the hypothalamus, where their final
maturation occurs (Wray, 2010). The early events that lead
to GnRH neuron specification and the origin of their
progenitors in the olfactory pit are currently poorly under-
stood.Manyexistingdata supportOPas the sourceofGnRH
neurons (Kim et al., 1999; Schwanzel-Fukuda and Pfaff,
1989; Wray et al., 1989a, 1989b), whereas others have pro-
posed that at least some GnRH neurons arise frommultiple
sources, such as the neural crest, and adenohypophyseal or
CNS progenitor cells (Forni et al., 2011; Markakis et al.,
2004; Salvi et al., 2009; Whitlock et al., 2003).
GnRH neuron specification occurs under explicit spatio-
temporal conditions, involving fibroblast growth factor 8
(FGF8) signaling and bone morphogenetic protein/trans-
forming growth factor b (BMP/TGF-b) pathway inhibitionStem Cell
This is an open access article under the C(Forni et al., 2013; Kawauchi et al., 2005; Rawson et al.,
2010). The indispensable role of FGF8 signaling through
fibroblast growth factor receptor 1 (FGFR1) in this process
has been established in various animal models (Chung
and Tsai, 2010; Sabado et al., 2012). These findings are
mirrored by reports in humans: mutations in FGF8 and
FGFR1 are found in patients with congenital hypogonado-
tropic hypogonadism, a rare genetic disease that causes
GnRH deficiency (Dode et al., 2003; Falardeau et al., 2008).
Human pluripotent stem cells (hPSCs), including embry-
onic stem cells (hESCs) and induced pluripotent stem cells
(hiPSCs), allow in vitro differentiation of specialized cell
types, including neurons (Chambers et al., 2009; Davis
et al., 2012; Hay et al., 2008). Here we report a protocol for
the generation of GnRH-expressing neurons from hPSCs.RESULTS
A schematic of the protocol is presented in Figure 1A. In the
first step, we employed dual SMAD inhibition on hPSCs by
blocking BMP and TGF-b/activin signaling pathways with
dorsomorphin (DM) and SB431542 (SB), respectively,
for 10 days to produce neural progenitor cells (NPCs)
(Chambers et al., 2009). This was followed by 10-day treat-
ment with FGF8, a key ligand in GnRH neuron develop-
ment, and 4–8 days of treatment with both FGF8 andReports j Vol. 7 j 149–157 j August 9, 2016 j ª 2016 The Author(s). 149
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Figure 1. Differentiation Protocol Schematic, and Expression of Anterior Neural Progenitor Markers after Neural Induction
(A) Schematic representation of the protocol. For the first 10 days the cells were treated with dual SMAD inhibition (dSMADi) using
dorsomorphin and SB431542. FGF8 was added at d11, and Notch inhibitor DAPT was added at d21.
(B) Real-time qPCR results at d10 showing an increased expression of pan-neural marker SOX1 and forebrain- and olfactory placode-
associated genes EMX2 and FOXG1. Preplacodal markers SIX1 and EYA1 remained low. Expression levels are relative to d0 hPSCs (HEL11.4
and H9 representative experiments, n = 6, mean ± SEM).
(legend continued on next page)
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Notch inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester), to induce terminal
maturation of the neurons (Borghese et al., 2010). We
used hiPSC line HEL11.4 (Mikkola et al., 2013), and hESC
line H9 (Thomson et al., 1998; WiCell) for differentiation
experiments, and the main results were repeated in hiPSC
line HEL24.3 (Trokovic et al., 2015). Both hiPSC lines
have been established from healthy donor fibroblasts.
Dual SMAD Inhibition Followed by FGF8 Treatment
Produces Highly Proliferating Neural Progenitor Cells
that Retain Anterior Identity
Ten days of dual SMAD inhibition induced early pan-neural
marker SOX1 and neural progenitor markers PAX6, EMX2,
and FOXG1 (Figure 1B), which are expressed in the devel-
oping forebrain and the OP (Duggan et al., 2008; Forni
et al., 2011; Simeone et al., 1992; Zhang et al., 2010). In
contrast, the expression of preplacodal genes EYA1 and
SIX1 (Ikeda et al., 2007; Schlosser et al., 2008) remained
low (Figure 1B). Immunocytochemical analyses confirmed
the expression of neural progenitor markers including
PAX6, FOXG1, and SOX2, whereas preplacodal marker
SIX1 was undetectable (Figure S1A). The expression levels
of ventral forebrain marker NKX2.1 and caudal markers
PAX5 and GBX2 (Kirkeby et al., 2012; Maroof et al., 2013)
were low (Figures 1C and S1B). These results indicate that
dual SMAD inhibition with DM and SB for 10 days effi-
ciently induces anteriorly patterned NPCs.
During the subsequent 10 days, the anteriorly primed
NPCswere treatedwith FGF8. At day 20 (d20), FGF8-treated
cells had further increased the expression of EMX2 and
FOXG1, as well as DLX2 and DLX5, which are also anteri-
orly expressed; in the frontonasal area, the OP, and the
anterior basal forebrain (Merlo et al., 2007; Simeone
et al., 1994) (Figures 1C and S1B). A high expression of
these anteriormarkers was sustained throughout the proto-
col, whereas the expressions of NKX2.1, PAX5, and GBX2
remained low (Figures 1C and S1B). Between d10 and
d20, the cells formed neural rosettes that abundantly ex-
pressed both SOX2 and FOXG1 (Figure 1D). Overall, an
average of 93% (±0.9%, n = 5) of cells were FOXG1 positive
at d21. FGF8-treated cells expanded more rapidly than
the controls (Figure S1C). Proliferation occurred pre-
dominantly in the rosette structures, as judged by
abundant Ki-67 expression (Figure 1D). Neural-specific
TUJ1-positive cells, which were consistently negative for
Ki-67, were located at the periphery and around the neural(C) Relative expression of anterior neural progenitor (EMX2, FOXG1, D
(PAX5 and GBX2) in FGF8-treated cells confirming anterior neural iden
from H9-derived cells are shown in Figure S1B.
(D) Immunocytochemistry at d21 revealed an abundant expression o
mainly outside the neural rosette structures. HEL11.4-derived cells. Srosettes, indicating neuronalmaturation and cell-cycle exit
(Figure 1D).
FGF8 and Subsequent Notch Inhibition Induces GnRH
Expression
To induce the terminal differentiation of NPCs, we in-
hibitedNotch signalingwithDAPT fromd21 onward. After
4–8 days, the GNRH1 mRNA level was highly increased in
cells supplemented with FGF8, but not in the control
cells (Figures 2A and S2A). Immunofluorescence showed
presence of GnRH-positive cellsmostly in the peripheral re-
gions of condensed cell clusters (Figure 2Ba). The GnRH-
positive cells were bipolar and expressed neural marker
MAP2 (Figure 2Bb). Concurrently, the number of prolifer-
ating (Ki-67 positive) cells was low, and, importantly, no
GnRH and Ki-67 double-positive cells were observed (Fig-
ure 2C). This indicates that the GnRH-positive cells had
exited the cell cycle. The neural identity of the GnRH-ex-
pressing cells was further confirmed by double staining
with TUJ1 (Figures 2D and S2B). A proportion of the
GnRH-positive cells also expressed FOXG1 (Figure 2E).
On average, 15.1% (±1.6%, n = 4) of the HEL11.4-derived
cells and 12.2% (±4.2%, n = 3) of the H9-derived cells
were GnRH positive.
Secretion of GnRH Decapeptide
Human GnRH is translated as a 96-amino-acid prohor-
mone, which is processed by intracellular proteases to
form the secreted decapeptide. The GnRH decapeptide
was clearly detectable in the culture medium of the FGF8-
treated cells, but not of the control cells from d25 onward,
with the peak concentrations measured on d27 (Figures 3A
and S3A). High-magnification images of GnRH immuno-
positive cells showed a punctate staining pattern in the
majority of the cells, indicating vesicular packaging of
GnRH decapeptide (Figures 3B and S3B). Activated cas-
pase-3 (Porter and Janicke, 1999) was not present in the
GnRH-positive cells (Figure 3C), suggesting that the release
of GnRH was not due to cell death. FGF8-treated cells
readily responded to KCl-induced depolarization by 1.97-
fold higher GnRH decapeptide release (95% confidence
interval, 1.62–2.31) when compared with vehicle-treated
cells.
Migration of GnRH-Expressing Cells
GABAA receptor stimulation has been shown to decelerate
the migration of embryonic mouse GnRH neurons (CasoniLX2, and DLX5), ventral forebrain (NKX2.1), and caudal CNS markers
tity. HEL11.4-derived cells, n = 3 (mean + SEM). Corresponding data
f SOX2, FOXG1, and Ki-67 within neural rosettes. TUJ1 was found
cale bars, 100 mm.
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Figure 2. GnRH-Expressing Cells Emerge after Treatment with FGF8 and DAPT
(A) Relative expression of GNRH1 at the end of the protocol in HEL11.4-derived cells (n = 4), and H9-derived cells (n = 6) treated with or
without FGF8 (mean + SEM). **p < 0.01, ****p < 0.0001 (paired ratio t test).
(B–E) Immunocytochemistry in HEL11.4-derived cells at the end of the protocol. (B) GnRH-positive neurons appeared mostly in the
periphery of condensed node-like structures. These cells appeared to be interconnected by long cellular projections (a), which stained
positive for MAP2 (b). (C) The GnRH-expressing cells were not proliferating, as indicated by the absence of colocalization with Ki-67
staining. (D) The GnRH-positive cells also expressed neuron-specific marker TUJ1. See also Figure S2B. (E) At the end of the protocol, the
majority of the cells expressed FOXG1. Some of the GnRH-positive cells were also FOXG1 positive. All scale bars represent 50 mm.
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Figure 3. GnRH Decapeptide Secretion in Culture Medium of FGF8-Treated Cells
In the final differentiation step, secretion of GnRH decapeptide was detected in the culture medium of FGF8-treated cells, but not of the
control cells.
(A) Four independent experiments using HEL11.4-derived cells (left) and three independent experiments from H9-derived cells (right) are
shown. The insets in the control graphs show the same control values with smaller y-axis scale. See also Figure S3A.
(B) At high magnification the GnRH staining appeared in granular spots in both HEL11.4- and H9-derived cells, indicating vesicular
packaging of the decapeptide. ROI, region of interest. Scale bars, 50 mm. See also Figure S3B.
(C) GnRH and an apoptosis marker, cleaved caspase-3, were not co-expressed, suggesting that GnRH-release was not due to apoptosis.
HEL11.4-derived GnRH-expressing cells display normal nuclear morphology. Arrows indicate cleaved caspase-3 staining and nuclear
morphology of apoptotic cell. Scale bars, 20 mm.et al., 2012). Therefore, we investigated themigratory prop-
erties of our FGF8-treated cells with a gap-closure assay,
whereby d25 cells were allowed to migrate to an empty
area in the middle of the culture wells in the presence or
absence of GABAA receptor agonist muscimol (0.1 mM).
After 50 hr, significantly fewer cells had migrated to the
empty area in muscimol-treated wells than in control wells
(paired ratio t test, n = 4; p < 0.05).Detection of GnRH-Expressing Neurons in FOXG1-
Positive Frontonasal Tissues
As some GnRH cells were positive for FOXG1 in vitro, we
investigated whether GnRH neurons express FOXG1 also
in vivo. Immunohistochemistry on an 8-gestational-week
human fetus showed migrating GnRH neurons that
appeared in typical cell clusters, called the migratory
mass (Miller et al., 2010; Tarozzo et al., 1995; Wray et al.,Stem Cell Reports j Vol. 7 j 149–157 j August 9, 2016 153
Figure 4. GnRH, FOXG1, and TUJ1 in an
8-Gestational-Week Human Fetus
(A) Immunohistochemistry of coronal sec-
tions in a human fetus. GnRH was expressed
in the frontonasal area between the olfac-
tory epithelia (oe) and the nasal medial
cartilage (nmc), in migrating cells also
known as the migratory mass. These cells
were FOXG1-positive, including GnRH-ex-
pressing cells. The arrow in the top panel
indicates the area magnified in the middle
panel. GnRH-FOXG1 double-positive cells
were also detected in the ventral forebrain.
(B) TUJ1 was expressed in the migratory
mass cells, including GnRH-expressing cells.
Arrow indicates the area magnified on the
right. cp, cribriform plate; fb, forebrain; lv,
lateral ventricle; nmc, nasal medial carti-
lage; oe, olfactory epithelia; tn, terminal
nerve.1994). The cell clusters contained GnRH neurons, other
neurons, and glial cells that delaminated from the olfactory
epithelium and migrated toward the forebrain (Figure 4A).
Indeed, FOXG1 was expressed in the GnRH neurons, as
well as in other cells of the migratory mass and the olfac-
tory epithelium (Figure 4A). Many GnRH-positive cells
appeared also to stain with TUJ1 (Figure 4B).DISCUSSION
According to current understanding, GnRH neurons are
first formed during early embryogenesis in the olfactory
placode area, from where they migrate to the hypothala-
mus via the vomeronasal/terminal nerve fibers (Wray,154 Stem Cell Reports j Vol. 7 j 149–157 j August 9, 20162010). Once at their final destination, they mature and
become an integral part of the hypothalamic-pituitary-
gonadal axis. While the OP have been generally accepted
as a source of GnRH neurons, the exact origin of GnRH
neuron progenitors has remained controversial. Our results
show that GnRH-secreting cells can be efficiently differen-
tiated fromNPCs that express high levels of anterior neural
progenitor markers. The induction of neural commitment
in hPSCs by using dual SMAD inhibition leads by default
to anterior neural cell fates (Chambers et al., 2009; Kirkeby
et al., 2012; Pankratz et al., 2007). Indeed, our dual SMAD
inhibition-treated NPCs showed high expression of
FOXG1 and EMX2. Expressed in the frontonasal area,
where GnRH neurons first emerge, FOXG1, DLX2, and
DLX5 have been suggested to be involved in GnRH neuron
development (Duggan et al., 2008; Givens et al., 2005; Iyer
et al., 2010). Indeed, all of these markers were upregulated
along our differentiation protocol. Placodal markers SIX1
and EYA1 (Schlosser, 2014) were, however, not upregulated
at any time during this protocol.
Our results show that anterior NPCs can give rise to
GnRH-expressing cells when cultured with FGF8, which
has been shown to promote progenitor cell survival in
the anterior neural structures (Forni et al., 2013; Kawauchi
et al., 2005). In mouse anterior neural ridge, FGF8 has been
shown to positively regulate Foxg1 expression (Shimamura
and Rubenstein, 1997), and mouse embryos that carry
hypomorphic and conditional Fgf8 mutations display
reduced telencephalons, which is suggested to result from
a decreased Foxg1 expression (Storm et al., 2006). In our
model, FOXG1 expression persisted following FGF8 treat-
ment, and importantly, FOXG1 was also expressed in
migrating GnRH neurons of a human fetus.
The final step in our protocol comprised Notch inhibi-
tion, which induces neuronal maturation from progenitor
cells (Borghese et al., 2010; Imayoshi et al., 2010; Noisa
et al., 2014; Yoon and Gaiano, 2005). As expected, the
blocking of Notch in our FGF8-treated cells after d20 decel-
erated cell proliferation, increased the expression of
neuron-specific markers TUJ1 and MAP2, and induced
GNRH1 expression, with up to 15% of the cells being
immunopositive for GnRH. This efficiency is high,
given that humans only have few thousand GnRH
neurons. Two recent publications have reported hPSC
differentiation to hypothalamic-like neuroendocrine cells,
such as POMC-, aMSH-, and AGRP-secreting neurons (Mer-
kle et al., 2015;Wang et al., 2015). In both approaches, dual
SMAD inhibition in combination with SHH activation led
to ventral forebrain progenitor stage, as suggested by
marker expression patterns including high NKX2.1 and
low FOXG1 expression. It is noteworthy that these two pro-
tocols did not report an induction of GNRH1 expression,
which highlights the known differences in the embryonic
origin of these cells. In contrast, our protocol produced
GnRH-expressing cells with long cellular processes consis-
tent with previously described morphology of GnRH neu-
rons (Herde et al., 2013). The GABAA receptor agonist mus-
cimol suppressed the migration of GnRH-expressing cells,
in agreement with the studies performed in embryonic
mouse GnRH neurons (Casoni et al., 2012). In themajority
of GnRH-expressing cells the GnRH staining appeared
in punctate structures, indicating GnRH prepropeptide
processing to mature decapeptide and packaging into
secretory vesicles. The cultures indeed robustly secreted
GnRH into culture medium. Future studies are required to
further characterize the neuroendocrine properties of these
GnRH-expressing cells. Our protocol was reproducible in
hiPSCs, which implicates that it can be employed to modeldiseases that affect GnRH neuron specification, such as hy-
pogonadotropic hypogonadism due to congenital GnRH
deficiency.EXPERIMENTAL PROCEDURES
See also Supplemental Experimental Procedures.
Human Pluripotent Stem Cells
hESC line H9 ((Thomson et al., 1998); Wicell) and two hiPSC lines
HEL11.4 (Mikkola et al., 2013) and HEL24.3 (Trokovic et al., 2015)
were used in this study. hPSCs were maintained on Geltrex-coated
plates with StemPro or Essential 8 medium.
GnRH Neuron Differentiation
N2B27 mediumwas used throughout the differentiation protocol.
For d0–d10, medium was supplemented with dual SMAD inhibi-
tors, 2 mM dorsomorphin, and 10 mM SB431542 (Sigma). At day
11, dual SMAD inhibition was withdrawn and 100 ng/ml FGF8
(Peprotech) was added. From d21 onward, medium was supple-
mentedwith both FGF8 and 20 mMNotch inhibitor DAPT (Sigma).
Control cells did not receive FGF8 supplementation.
Analysis of GnRH Expression and Secretion
RNA extraction and real-time qPCRwere performed using standard
protocols. The expression levels of target genes were normalized to
cyclophilin G, and compared with undifferentiated hPSCs. For
immunocytochemistry, cells were fixed by 4% paraformaldehyde
and immunostainings were performed using standard protocols.
FOXG1 and GnRH immunopositive cells were quantified by
manually counting the cells in images taken with a 403 objective.
Secreted GnRH was quantified by a competitive fluorescent
enzyme immunoassay.
Human Samples
A human fetus (8 gestational weeks) was obtained from a volun-
tarily terminated pregnancy with the parent’s written informed
consent. Permission to utilize human fetal tissues was obtained
from the French agency for biomedical research (Agene de la
Biome´decine, Saint-Denis la Plaine, France, protocol no. PFS16-
002). Tissues were made available in accordance with French
bylaws. Tissues were fixed with 4% paraformaldehyde and immu-
nostaining was performed on 20-mm cryosections. Immunostain-
ing was performed according to standard procedures (INSERM).
Statistical Analyses
When used, ‘‘n’’ always stands for number of independent experi-
ments. Statistical comparisons were performed by using paired
ratio t test in Prism 5.0 (GraphPad). p < 0.05 was accepted to indi-
cate statistical significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and two tables and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2016.06.007.Stem Cell Reports j Vol. 7 j 149–157 j August 9, 2016 155
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